Article
Genetic mutations associated with blood count abnormalities in myeloid neoplasms.
Hematology (Amsterdam, Netherlands) - 1 Dec 2022
Polprasert Chantana, Kongkiatkamon Sunisa, Niparuck Pimjai, Rattanathammethee Thanawat, Wudhikarn Kitsada, Chuncharunee Suporn, Kobbuaklee Sirorat, Suksusut Amornchai, Lanamtieng Theerin, Lawasut Panisinee, Asawapanumas Thiti, Bunworasate Udomsak, Rojnuckarin Ponlapat
Abstract excerpt
INTRODUCTION: Myelodysplastic syndromes (MDS) predominantly present with varying degrees of cytopenia, while myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) exhibit proliferative features. Genetic defects underlying different complete blood count (CBC) alterations remain to be defined. OBJECTIVE: We aimed to evaluate mutations and impacts on abnormal blood counts in MDS and MDS/MPN. METHOD: MDS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.